CAMBRIDGE, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the company will host a conference call and live webcast on Thursday, October 30, 2025, at 8:00 a.m. ET to report its third quarter 2025 financial results and business highlights. The live webcast will be accessible on the Investors section of the company’s website (www.agios.co ...

Director Paul Schimmel's purchase of 317,999 shares signals insider confidence in aTyr Pharma, Inc. (NASDAQ:ATYR)'s future prospects.The company is currently involved in a class action lawsuit, which could affect investor sentiment and its reputation.aTyr's financials show challenges with a negative P/E ratio of -1.29 and a negative enterprise value to operating cash flow ratio of -1.60, but it maintains a low debt-to-equity ratio of 0.17 and a strong current ratio of 5.63.aTyr Pharma, Inc. (NASDAQ:ATYR) is ...